• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OLYMPUS TERUMO BIOMATERIALS CORP. MISHIMA FACTORY OSFERION; FILLER, BONE VOID, CALCIUM COMPOUND

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OLYMPUS TERUMO BIOMATERIALS CORP. MISHIMA FACTORY OSFERION; FILLER, BONE VOID, CALCIUM COMPOUND Back to Search Results
Model Number OSFERION
Device Problem Insufficient Information (3190)
Patient Problems Unspecified Infection (1930); Necrosis (1971)
Event Type  Injury  
Manufacturer Narrative
The device history record was reviewed, and no irregularities were noted.Meanwhile, we cannot rule out the possibility that this event was caused by either other intraoperative factors or other factors related to postoperative management.Because this product (referenced in this report) was not returned to olympus (b)(4) for evaluation, the cause of the adverse event has not been specified.The osferion bone void filler package insert states in the following section: adverse events: infection; fever,pain,local sensation,red flare,inflammation.This report is being submitted as a medical device report is an abundance of caution.
 
Event Description
A patient underwent high tibial osteotomy (hto).During the surgery, the surgeon in charge of the patient fixed the osteotomized tibia with a metal plate and bone screws and implanted this product (bone void filler) into the bone defect formed after the osteotomy.After the surgery, however, the surgeon confirmed that the patient was developing a surgical site infection.The patient therefore underwent debridement of necrotic tissue and wound irrigation.Comments of the surgeon: since no symptom of infection was observed in the patient's knee joint, the surgeon hastened to carry out debridement of necrotic tissue and wound irrigation.The surgeon assume that an additional surgery would be necessary to remove the plate and screws in the near future.This product would not be an immediate cause of this adverse event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OSFERION
Type of Device
FILLER, BONE VOID, CALCIUM COMPOUND
Manufacturer (Section D)
OLYMPUS TERUMO BIOMATERIALS CORP. MISHIMA FACTORY
454-1 higashino,nagaizumi-cho
sunto-gun
shizuoka, 411-0 931
JA  411-0931
Manufacturer (Section G)
OLYMPUS TERUMO BIOMATERIALS CORP.
1-50-1 sasazuka,shibuya-ku
151-0 073
JA   151-0073
Manufacturer Contact
jiro hirai
1-50-1 sasazuka,shibuya-ku
tokyo, 151-0-073
JA   151-0073
57383961
MDR Report Key6088178
MDR Text Key59456908
Report Number3007738819-2016-00006
Device Sequence Number1
Product Code MQV
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K080065
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Reporter Occupation Physician
Type of Report Initial
Report Date 10/19/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/31/2020
Device Model NumberOSFERION
Device Catalogue Number60A5
Device Lot NumberM15X04B747
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/19/2016
Initial Date FDA Received11/08/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/03/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-